Clinical Trials Browser

Phase 2 × OTHER_GOV × surufatinib × Clear all

NCT05595889 2022-11-29

Surufatinib Combined With Irinotecan as a Second-line Treatment for Small Cell Lung Cancer

Phase 2 Unknown

Small Cell Lung Carcinoma

NCT04764006 2021-11-04

Surufatinib Combined With Sintilimab for Advanced MSS-Type Colorectal Cancer : a Phase II Study

Phase 2 Unknown

Gastrointestinal

Advanced Colorectal Cancer